Fulgent Genetics, Inc. FLGT
Set alert
20.62 USD -1.06 -4.89%
At close · Oct 30
20.62 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
20.55 Day range 21.50
13.79 52-week range 30.85
- YTD
- -21.51%
- 1 year
- -8.68%
- Open
- 21.50
- Prev close
- 21.68
- Mkt cap
- 567.37M
- Vol
- 201.37K
- Avg vol
- 305.89K
- EPS
- -2.82
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 20.55
- High
- 21.50
- Forward P/E
- -36.45
- Beta
- 1.51
- Short ratio
- 2.87
- Inst. own
- 54.30%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 19.48
- 200-d avg
- 21.08
- 1y target
- 27.67
Financial health
Altman Z-Score
4.71 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -13.3×
FY 2016 5y median -5.1× FY 2025
P/S 2.5×
FY 2016 5y median 2.5× FY 2025
P/B 0.7×
FY 2016 5y median 0.7× FY 2025
P/FCF -6.5×
FY 2016 5y median 3.8× FY 2025
EV/EBITDA -16.7×
FY 2016 5y median -5.3× FY 2025
EV/Sales 2.4×
FY 2016 5y median 2.4× FY 2025
FCF Yield -15.4%
FY 2016 5y median 0.6% FY 2025
Profitability
Gross Margin 40.6%
FY 2016 5y median 40.6% FY 2025
Operating Margin -28.2%
FY 2016 5y median -26.1% FY 2025
Net Margin -18.8%
FY 2016 5y median -15.1% FY 2025
ROE -5.4%
FY 2016 5y median -3.8% FY 2025
ROIC -7.1%
FY 2016 5y median -5.4% FY 2025
ROA -5.0%
FY 2016 5y median -3.5% FY 2025
Growth (YoY)
Revenue 13.8%
FY 2016 FY 2025
Operating Income -23.2%
FY 2016 FY 2025
EPS (diluted) -39.7%
FY 2016 FY 2025
Free Cash Flow -545.1%
FY 2016 FY 2025
Financial Health
Current Ratio 6.5×
FY 2016 5y median 6.5× FY 2025
Quick Ratio 6.4×
FY 2016 5y median 6.4× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2016 5y median 0.6× FY 2025
Interest Coverage -1215×
FY 2016 5y median -401× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31